Titles and Roles
- Assistant Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Research Program
- Discovery and Developmental Therapeutics
Jane Lowe Meisel, MD, is an Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. She joined the Glenn Family Breast Center at Winship Cancer Institute as a practicing physician in January 2015. Prior to her arrival, she was Chief Fellow at Memorial Sloan Kettering Cancer Center in New York.
Dr. Meisel is a medical oncologist with a special interest in women's health and in cancers that affect women, including breast, cervical, endometrial, and ovarian cancers. Her goal is to provide exceptional, state-of-the-art individualized care to patients fighting these diseases and to conduct research that improves treatment options for these patients.
Dr. Meisel is a member of the Development Therapeutics Committee at NRG Oncology and a member of the Cancer Education Committee at American Society of Clinical Oncology.
A native of Atlanta, Dr. Meisel graduated magna cum laude from Harvard College in 2004 with a degree in the History of Science, and earned her medical degree in 2008 from Harvard Medical School. She completed her residency in internal medicine at Brigham and Women’s Hospital in Boston, MA in 2011; during that time, she also conducted research on breast cancer at the Dana-Farber Cancer Institute. She completed her fellowship in medical oncology at Memorial Sloan Kettering Cancer Center in New York, NY, and served as Chief Fellow there from 2013 to 2014.
Dr. Meisel has presented her research on breast cancer and gynecologic malignancies at national meetings and has published her work in peer-reviewed journals. Her research is focused on the development of new therapeutic options for women with gynecologic and breast cancers, and on improving quality of life for these patients. Her work has also focused on gaining a better understanding of the genetic mutations that confer susceptibility to breast and ovarian cancer, such as the BRCA1 and BRCA2 genes.
Below is a listing of current federal grants for the above principal investigator.
Publications Publication Date
Dr. Meisel has received several teaching awards, including the Resident Mentor Award and Notable Teaching Award at Brigham and Women's Hospital.
She received an American Society for Clinical Oncology (ASCO) Young Investigator Award in 2014 for her work evaluating the use of circulating tumor DNA to detect platinum resistance in patients with BRCA mutations and recurrent ovarian cancer.